BridgeMD
New treatment option for Colles Fracture
Official title Comparison of Kaltenborn Mobilization and Mobilization With Movement (MWM) in Wrist Hypomobility After Colle's Fracture
ClinicalTrials.gov ID: NCT07060430
What this study is testing
- What it's testing
- This study is a randomised control trial and the purpose of this study is to determine comparision of Kaltenborn Mobilization and Mobilization with Movement (MWM) in wrist Hpomobility after Colle's fracture.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 40 to 70
You may be able to join if
- Both male and female participants (40-70 years old) Participants who will have diagnosed Colle's fracture and treated conservatively by plaster cast...
You likely can't join if
- Patients having diagnosed Colle's fracture and treated with invasive procedure like K wiring, ORIF etc.
- Patient with Neuromuscular injuries.(diagnosed)
- Rheumatoid arthritis.
- Patients with metacarpal fracture or compartment syndrome, non-union.(diagnosed)
The study team makes the final eligibility decision.
Where it's taking place
- Islamabad, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 40 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Islamabad, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.